Linked Life Data

19136883

Source:http://linkedlifedata.com/resource/pubmed/id/19136883

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-1-12
pubmed:abstractText
Hepatocyte transplantation (HCTx) has been considered as an alternative to orthotopic liver transplantation for the treatment of acute and chronic liver failure and metabolic liver diseases. One of the factors that mainly limit its application is the significant cellular loss after HCTx. Although liver has been considered as an immunologically privileged organ, transplanted hepatocytes can only survive for 7 to 10 days without immunosuppression. In fact, both innate and adaptive immune system are implicated in the destruction to allografts, which is a particular type of rejection. This article has reviewed the progress in the mechanisms of cellular loss after allogenic HCTx.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1534-6080
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-5
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Cellular loss after allogenic hepatocyte transplantation.
pubmed:affiliation
Department of Hepatobiliary Surgery, First Affiliated Hospital of Medical College, Xi'an Jiaotong University, Shaanxi Province, China.
pubmed:publicationType
Journal Article, Review